Vineta

EQS-News: CRS initiates new chapter by appointing leading industry expert Elisabeth Lackner as Chief Executive Officer

Retrieved on: 
Wednesday, April 10, 2024

Mannheim, Germany, March 15, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), today announced the appointment of Dr. Elisabeth Lackner as Chief Executive Officer (CEO), effective today.

Key Points: 
  • Mannheim, Germany, March 15, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), today announced the appointment of Dr. Elisabeth Lackner as Chief Executive Officer (CEO), effective today.
  • Dr. Elisabeth Lackner, CEO of CRS, commented: “I am honoured to join this great management team and to guide the organization into its next chapter of strategic growth and innovation.
  • “Together, we aim to propel CRS to new heights, centred on internationalization, strategic expansion, and a relentless pursuit of excellence."
  • Dr. Lackner is a highly experienced and well-respected global thought leader with over 20 years of experience in the healthcare industry.

DGAP-News: Element drives global life science strategy with appointment of industry expert Dr. Elisabeth Lackner as Chief Scientific Officer

Retrieved on: 
Thursday, June 30, 2022

Element drives global life science strategy with appointment of industry expert Dr. Elisabeth Lackner as Chief Scientific Officer

Key Points: 
  • Element drives global life science strategy with appointment of industry expert Dr. Elisabeth Lackner as Chief Scientific Officer
    The issuer is solely responsible for the content of this announcement.
  • LONDON, UK June 30, 2022 Element Materials Technology (Element), a leading global Testing, Inspection and Certification (TIC) company, has appointed Dr. Elisabeth Lackner as Chief Scientific Officer (CSO).
  • In the newly created CSO role, Dr. Lackner joins the Operating Board ensuring that Element is positioned at the leading-edge of scientific thinking.
  • In her new role as Chief Scientific Officer, Elisabeth will help us respond and mobilize to global trends affecting this industry, combining her scientific expertise and proven leadership skills.

Element drives global life science strategy with appointment of industry expert Dr. Elisabeth Lackner as Chief Scientific Officer

Retrieved on: 
Thursday, June 30, 2022

LONDON, June 30, 2022 (GLOBE NEWSWIRE) -- Element Materials Technology (Element), a leading global Testing, Inspection and Certification (TIC) company, has appointed Dr. Elisabeth Lackner as Chief Scientific Officer (CSO).

Key Points: 
  • LONDON, June 30, 2022 (GLOBE NEWSWIRE) -- Element Materials Technology (Element), a leading global Testing, Inspection and Certification (TIC) company, has appointed Dr. Elisabeth Lackner as Chief Scientific Officer (CSO).
  • In the newly created CSO role, Dr. Lackner joins the Operating Board ensuring that Element is positioned at the leading-edge of scientific thinking.
  • In her new role as Chief Scientific Officer, Elisabeth will help us respond and mobilize to global trends affecting this industry, combining her scientific expertise and proven leadership skills.
  • Elisabeth will help Element to create a global platform for Life Sciences, with integrated support for the medicinal product and medical device industries.